First Washington Corp’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

First Washington Corp’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-317,450	Closed	-$549K	–	94
2015 Q4	$549K	Sell	317,450 -1,800	-0.6%	-$3.17K	0.32%	46
2015 Q3	$591K	Hold	319,250	–	–	0.36%	51
2015 Q2	$747K	Buy	319,250 +130,400	+69%	+$402K	0.42%	49
2015 Q1	$827K	Buy	188,850 +3,600	+2%	+$18.1K	0.48%	45
2014 Q4	$893K	Hold	185,250	–	–	0.53%	43
2014 Q3	$771K	Sell	185,250 -9,190	-5%	-$42.8K	0.44%	47
2014 Q2	$1.15M	Buy	194,440 +8,740	+5%	+$49.6K	0.64%	47
2014 Q1	$1.19M	Buy	185,700 +72,700	+64%	+$656K	0.68%	44
2013 Q4	$1.08M	Buy	+113,000	New	+$882K	0.58%	47

Other funds holding TLOG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

First Washington Corp's TLOG Position: Q1 2016 in Review

First Washington Corp sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2016, closing a stake of 317,450 shares — an estimated $549K sold.

First Washington Corp first reported a position in TLOG in Q4 2013 and held it in 9 quarters. The position peaked at $1.19M in Q1 2014. 25 funds tracked by Wall St. Rank hold TLOG as of Q1 2016.

First Washington Corp reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2016 after selling out during the quarter.
First Washington Corp sold 317,450 TetraLogic Pharmaceuticals Corporation shares in Q1 2016, an estimated $549K.
First Washington Corp first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 9 quarters.
First Washington Corp's TetraLogic Pharmaceuticals Corporation position peaked at $1.19M in Q1 2014.
25 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2016.

Based on First Washington Corp's 13F filing for Q1 2016, filed 9 May 2016.